Hot Sectors

Covering the fastest growing and most talked about sectors in the market.

Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center Edges Closer for Hemispherx Biopharma
13 May
2019
Written by Mike Elliott

Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center Edges Closer for Hemispherx Biopharma »

According to the latest news from the company, Roswell Park now has FDA authorization to proceed with its Phase 2 study investigating the effectiveness and safety of aspirin and Ampligen with or without interferon-alpha 2b (Intron A) compared to no drug treatments in a randomized three-arm study of patients with prostate cancer before undergoing radical prostatectomy.

Read more...
Which ESports Stocks You Should Be Watching and Why?
1 Apr
2019
Written by Mike Elliott

Which ESports Stocks You Should Be Watching and Why? »

Esports is entering a tremendous growth phase. The global esports economy is expected to grow to more than $905 million this year, according to market research firm Newzoo. That figure would represent year-over-year growth of roughly 38%.

Read more...
OrignClear (OCLN) Going After Multi-Billion Dollar Water Treatment Systems Market
1 Oct
2018
Written by Mike Elliott

OrignClear (OCLN) Going After Multi-Billion Dollar Water Treatment Systems Market »

In this episode of the CEOLIVE Investor Profile series, we're joined again by Riggs Eckelberry, CEO of OriginClear, a leading provider of water treatment solutions that trades under ticker OCLN.

Read more...
BioSig (BSGM) Continues to Advance with FDA 510(K) Clearance and NASDAQ Uplisting on the Horizon
29 Aug
2018
Written by Mike Elliott

BioSig (BSGM) Continues to Advance with FDA 510(K) Clearance and NASDAQ Uplisting on the Horizon »

In the interview, Ken discusses the recent 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA).

Read more...
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
18 Jul
2018
Written by Mike Elliott

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market »

In this episode of the CEOLIVE Investor Profile series, we’re joined by Ken Londoner, Chairman, and CEO of BioSig Technologies, ticker BSGM.

Read more...
Precision Therapeutics (AIPT) Bringing Big Data and AI to Precision Medicine
26 Mar
2018
Written by Mike Elliott

Precision Therapeutics (AIPT) Bringing Big Data and AI to Precision Medicine »

Precision Therapeutics (AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.

Read more...

Login

Lost your password?